[Polypeptide "substance P": pathophysiologic aspects].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004064:Digestive System / Q000187:drug effects; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000502:physiology; D010525:Peripheral Nerves / Q000503:physiopathology; D013373:Substance P / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*
D018377:Neurotransmitter Agents; D013373:Substance P
Polipetidnaia "substantsiia P": patofiziologicheskie aspekty.